Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy

Yan-zhi Chen; Zhan-dong Li; Ning Zhou; Hong Sun; Ping-ping Li

doi:10.1007/s11655-012-1171-2

Your Location：

Home >

Browse articles >

Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy

Updated：2021-08-27

- Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy
- Chinese Journal of Integrative Medicine Vol. 18, Issue 8, Pages: 626-628(2012)
- Affiliations：
  
  Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Beijing Cancer Hospital and Institute,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-012-1171-2
  CLC：
- Published：2012，
  
  Published Online：2 August 2012，
Scan for full text
Chen, Yz., Li, Zd., Zhou, N. et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy., Chin. J. Integr. Med. 18, 626–628 (2012). https://doi.org/10.1007/s11655-012-1171-2

Yan-zhi Chen, Zhan-dong Li, Ning Zhou, et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy. [J]. Chinese Journal of Integrative Medicine 18(8):626-628(2012)
Chen, Yz., Li, Zd., Zhou, N. et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy., Chin. J. Integr. Med. 18, 626–628 (2012). https://doi.org/10.1007/s11655-012-1171-2 DOI：

Yan-zhi Chen, Zhan-dong Li, Ning Zhou, et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy. [J]. Chinese Journal of Integrative Medicine 18(8):626-628(2012) DOI： 10.1007/s11655-012-1171-2.

摘要

Abstract

关键词

Epidermal Growth Factor Receptor MutationMucinous AdenocarcinomaAstragalus membranaceusDocetaxel TherapyEnlarge Mediastinal Lymph Node

Keywords

Epidermal Growth Factor Receptor MutationMucinous AdenocarcinomaAstragalus membranaceusDocetaxel TherapyEnlarge Mediastinal Lymph Node

references

Walker S. Updates in non-small cell lung cancer. Clin J Oncol Nurs 2008;12:587–596.

Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. J Clin Oncol 2002;20:4285–4291.

Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958–967.

Chen YZ, Li ZD, Gao F, Zhang Y, Sun H, Li PP. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chin J Integr Med 2009;15:415–419.

Chen YZ, Di LJ, Zhang SL, Chen MS, Sun H, Gao F, et al. The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional Chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy. Chin J Lung Cancer (Chin) 2008;11:441–444.

Li HJ, Wang H, Fang QH, Zhang GQ. Effects of Kanglaite on apoptosis and apoptotic protein procaspase-3 and caspase-9 expression in hepatic carcinoma BEL-7404 cells. Tumor (Chin) 2010;30:740–743.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of Sanqi Oral Liquid (三芪口服液) on the expressions of CD4+, CD8+ and CD68+ cells in 5/6 nephrectomized rats with chronic renal failure

Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-γ production by up-regulating T-bet expression in patients with asthma

Study on diagnosis and treatment of infectious multiple organ dysfunction syndrome by integrated traditional Chinese and Western medicine

Effects of astragalus membranaceus on urinary endothelin in patients with incipient diabetic nephropathy

Modified buyang huanwu decoction in treating 65 patients of renal syndrome hemorrhagic fever

Related Author

No data

Related Institution

Guangzhou University of Chinese Medicine

Pharmaceutical Manufacturing Section, Guangdong Provincial Hospital of Traditional Chinese Medicine

Epidemiological Teaching and Research Section, Guangdong Provincial Hospital of Traditional Chinese Medicine

Animal Laboratory Center, Guangdong Provincial Hospital of Traditional Chinese Medicine

Clinical Laboratory, Guangdong Provincial Hospital of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰